Home/Filings/4/0001415889-23-002181
4//SEC Filing

Macuga Daniel A. 4

Accession 0001415889-23-002181

CIK 0000896264other

Filed

Feb 7, 7:00 PM ET

Accepted

Feb 8, 9:42 PM ET

Size

15.8 KB

Accession

0001415889-23-002181

Insider Transaction Report

Form 4
Period: 2023-02-06
Macuga Daniel A.
Chief Communications Officer
Transactions
  • Exercise/Conversion

    Common Stock

    2023-02-07+1,5815,728 total
  • Award

    Restricted Stock Units

    2023-02-06+10,01123,564 total
    Common Stock (10,011 underlying)
  • Exercise/Conversion

    Restricted Stock Units

    2023-02-071,58121,983 total
    Common Stock (1,581 underlying)
  • Tax Payment

    Common Stock

    2023-02-07$59.76/sh670$40,0395,058 total
  • Tax Payment

    Common Stock

    2023-02-08$61.53/sh711$43,7486,024 total
  • Exercise/Conversion

    Common Stock

    2023-02-08+1,6776,735 total
  • Exercise/Conversion

    Restricted Stock Units

    2023-02-081,67720,306 total
    Common Stock (1,677 underlying)
Footnotes (4)
  • [F1]Each restricted stock unit represents a contingent right to receive one share of USNA common stock.
  • [F2]On February 6th, 2023, the reporting person was granted restricted stock units, vesting at 25% on each 6th of February thereafter.
  • [F3]Restricted Stock Units vest 25% on the anniversary of February 7th, 2022.
  • [F4]Restricted Stock Units vest 25% on the anniversary of February 8th, 2021.

Issuer

USANA HEALTH SCIENCES INC

CIK 0000896264

Entity typeother

Related Parties

1
  • filerCIK 0001537768

Filing Metadata

Form type
4
Filed
Feb 7, 7:00 PM ET
Accepted
Feb 8, 9:42 PM ET
Size
15.8 KB